comparemela.com

Latest Breaking News On - Prnewswire versanis bio - Page 1 : comparemela.com

Versanis Bio to Present New Clinical Data at American Diabetes Association 83rd Scientific Sessions

/PRNewswire/ Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for obesity and other cardiometabolic.

San diegoUnited statesLouisj aronneKennethm attiePrnewswire versanis bioShalender bhasinDiego bayfrontStevenb heymsfieldAmerican diabetes associationScientific sessionsChief medical officerWeight lossReduced fat massIncreased muscle massOptimized weight lossBariatric surgery

Versanis Bio Announces Completion of Enrollment of the BELIEVE Phase 2b Study in Patients with Obesity

/PRNewswire/ Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for obesity and other cardiometabolic.

Mark pruzanskiPrnewswire versanis bioKen attieVersanis bio

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity

/PRNewswire/ Versanis Bio ("Versanis"), a clinical-stage biopharmaceutical company advancing novel therapeutics for cardiometabolic diseases, today.

New zealandPrnewswire versanis bioKenneth attieChief medical officerVersanis bio

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New zealandPrnewswire versanis bioVersanis bioKenneth attieAditum bioAtlas ventureChief medical officer

Versanis Bio Announces Leadership and Board Appointments as Company Prepares to Initiate Phase 2b Study with Novel Approach to Obesity

/PRNewswire/ Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, today announced three.

United statesNick williamsDarby pearsonMark fishmanMark pruzanskiMichael gladstonePrnewswire versanis bioBarbara duncanVersanis bioJohn maraganoreJoe jimenezAditum bioLloyd klicksteinJohns hopkins universityInternational affairsMcmaster university medical school

vimarsana © 2020. All Rights Reserved.